This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Theravalues Corporation. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shinjuku-ku, JP (2020)
- Shinjuku, JP (2024)
Company Filing History:
Years Active: 2020-2024
Title: Tomonori Yaguchi: Innovator in Cancer Therapeutics
Introduction
Tomonori Yaguchi is a prominent inventor based in Shinjuku-ku, Japan. He has made significant contributions to the field of cancer therapeutics, holding 2 patents that focus on enhancing treatment efficacy.
Latest Patents
Yaguchi's latest patents include a therapeutic agent for cancer aimed at providing a higher therapeutic effect. This agent contains at least one component selected from curcumin and its derivatives, combined with at least one from a group consisting of anti-PD-1, anti-PD-L1, and anti-PD-L2 antibodies. Another patent focuses on the formulation of curcumin and the anti-PD-1 antibody, reinforcing the goal of improving cancer treatment outcomes.
Career Highlights
Tomonori Yaguchi is associated with Theravalues Corporation, where he continues to innovate in the realm of cancer therapies. His work is pivotal in developing new treatment options that could potentially change the landscape of cancer care.
Collaborations
Yaguchi collaborates with notable colleagues, including Yutaka Kawakami and Taeko Hayakawa, to advance research and development in cancer therapeutics.
Conclusion
Tomonori Yaguchi's contributions to cancer treatment through his innovative patents highlight his commitment to improving patient outcomes. His work at Theravalues Corporation and collaborations with esteemed colleagues further emphasize his role as a key figure in the field of medical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile